Stay updated on IpilimumabNivolumabLeptoMetClinicalTrial
Sign up to get notified when there's something new on the IpilimumabNivolumabLeptoMetClinicalTrial page.

Latest updates to the IpilimumabNivolumabLeptoMetClinicalTrial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a dedicated Locations section detailing Massachusetts-based study sites (e.g., Boston; Massachusetts General Hospital). Removed the Massachusetts Locations entry and the HHS Vulnerability Disclosure from the footer; page revision updated to v3.3.3.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed, replacing the previous description, and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedAdministrative metadata updates were added, including new timestamps such as Last Update Posted (Estimated) and dates like 2025-11-14 and 2025-10-30, with no changes to trial design, eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check70 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page; the content and layout appear unchanged between versions.SummaryDifference0.4%

- Check91 days agoChange DetectedMajor update: new operating-status notice and a v3.2.0 release; v3.1.0 is removed.SummaryDifference2%

- Check98 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to IpilimumabNivolumabLeptoMetClinicalTrial
Enter your email address, and we'll notify you when there's something new on the IpilimumabNivolumabLeptoMetClinicalTrial page.